Noticias de GLSI_US

Noticias del mercado

Últimas noticias sobre GLSI_US — 115 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: GLSI_US ✕ 115 resultados
26/04/2026 GLSI_US — MSN
Why did Greenwich LifeSciences stock soar pre-market today?
25/04/2026 GLSI_US — MarketBeat ES ← EN
Greenwich LifeSciences (NASDAQ:GLSI) corta para "vender" en Wall Street Zen

Wall Street Zen rebajó las acciones de Greenwich LifeSciences de una calificación de "mantener" a una calificación de "vender" en una nota de investigación el sábado.

24/04/2026 GLSI_US — MSN
Why is GLSI stock rising today?
24/04/2026 GLSI_US — MSN ES ← EN
¿Por qué están subiendo las acciones de GLSI hoy?

Why is GLSI stock rising today?

23/04/2026 GLSI_US — Traders Union
ASCO 2026 to feature Greenwich LifeSciences research poster
23/04/2026 GLSI_US — GlobeNewswire ES ← EN
Greenwich LifeSciences anuncia la aceptación del resumen en ASCO 2026

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026

23/04/2026 GLSI_US — tayninh.gov.vn
GLSI (Greenwich LifeSciences Inc.) reports narrow Q3 2025 EPS beat, shares climb 2.36 percent on positive investor sentiment. - Hedge Fund Inspired Picks
23/04/2026 GLSI_US — MarketBeat
HC Wainwright Has Bearish Estimate for GLSI FY2026 Earnings
23/04/2026 GLSI_US — Stock Titan
Breast cancer immunotherapy study lands ASCO 2026 poster slot
23/04/2026 GLSI_US — ChartMill
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
23/04/2026 GLSI_US — Sahm ES ← EN
Greenwich LifeSciences anuncia la recepción de un aviso de Nasdaq sobre la presentación tardía del formulario 10-K

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

22/04/2026 GLSI_US — The Globe and Mail ES ← EN
Greenwich LifeSciences anuncia la recepción de un aviso de Nasdaq sobre la presentación tardía del formulario 10-K

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing

22/04/2026 GLSI_US — sonla.gov.vn
GLSI (Greenwich LifeSciences Inc.) reports narrow Q3 2025 EPS beat, shares climb 2.36 percent on positive investor sentiment. - Secondary Offering
22/04/2026 GLSI_US — Yahoo Finance
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
22/04/2026 GLSI_US — Stock Titan
Nasdaq flags Greenwich LifeSciences over delayed 2025 annual report
22/04/2026 GLSI_US — GlobeNewswire
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
22/04/2026 GLSI_US — ChartMill
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
21/04/2026 GLSI_US — Stock Traders Daily
(GLSI) as a Liquidity Pulse for Institutional Tactics
20/04/2026 GLSI_US — Yahoo Finance
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
20/04/2026 GLSI_US — Stock Titan
Breast cancer immunotherapy shows 4x immune response in Phase III data

Página 2 de 6

keyboard_arrow_up